- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| VENUS MEDTECH Aktie jetzt für 0€ handeln | |||||
| Mo | VENUS MEDTECH-B (02500): DISCLOSEABLE TRANSACTION IN RELATION TO DISPOSAL OF SHARES OF AN INVESTEE COMPANY | 1 | HKEx | ||
| 24.12.25 | VENUS MEDTECH-B (02500): VOLUNTARY ANNOUNCEMENT SUBMISSION OF CE MDR MARKING APPLICATION FOR THE CARDIOVALVE TRICUSPID VALVE REPLACEMENT | 2 | HKEx | ||
| 28.11.25 | VENUS MEDTECH-B (02500): POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING | 1 | HKEx | ||
| 19.11.25 | VENUS MEDTECH-B (02500): VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE | 1 | HKEx | ||
| 17.11.25 | Venus Medtech (Hangzhou) Inc.: Cardiovalve Submits CE File for Approval Following Successful TARGET Study Completion | 259 | PR Newswire | Exciting Data on Cardiovalve Tricuspid Valve Replacement Device Presented at PCR London Valves 2025 meeting.
LONDON, Nov. 17, 2025 /PRNewswire/ -- Venus Medtech... ► Artikel lesen | |
| 14.11.25 | VENUS MEDTECH-B (02500): SUPPLEMENTAL ANNOUNCEMENT PROPOSED ISSUE OF CONVERTIBLE BONDS UNDER GENERAL MANDATE AND ENTRY INTO THE SUPPLEMENTAL AGREEMENTS | - | HKEx | ||
| 12.11.25 | VENUS MEDTECH-B (02500): PROXY FORM FOR USE AT THE EGM | - | HKEx | ||
| 12.11.25 | VENUS MEDTECH-B (02500): NOTICE OF EXTRAORDINARY GENERAL MEETING | 3 | HKEx | ||
| 12.11.25 | VENUS MEDTECH-B (02500): (1) MAJOR TRANSACTION IN RELATION TO DISPOSAL OF PROPERTY AND (2) NOTICE OF EXTRAORDINARY GENERAL MEETING | 3 | HKEx | ||
| 12.11.25 | BRIEF: Venus Medtech sells Hangzhou project for 375 million yuan | 2 | Bamboo Works | ||
| 11.11.25 | VENUS MEDTECH-B (02500): MAJOR TRANSACTION IN RELATION TO DISPOSAL OF PROPERTY CLOSURE OF REGISTER OF MEMBERS AND CHANGE IN USE OF PROCEEDS FROM THE INITIAL ... | 1 | HKEx | ||
| 27.10.25 | Venus Medtech's Cardiovalve completes enrollment in tricuspid valve replacement trial | 1 | MassDevice | ||
| 25.10.25 | Venus Medtech (Hangzhou) Inc.: Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement | 651 | PR Newswire | The Company Advances Toward European CE Mark Submission with 150 Patients Enrolled; On Track for 2027 Commercial Launch
HANGZHOU, China, Oct. 25, 2025 /PRNewswire/... ► Artikel lesen | |
| 24.10.25 | VENUS MEDTECH-B (02500): VOLUNTARY ANNOUNCEMENT COMPLETION OF FULL PATIENT ENROLLMENT FOR CONFIRMATORY CLINICAL STUDY OF CARDIOVALVE TTVR | - | HKEx | ||
| 29.09.25 | VENUS MEDTECH-B (02500): 2025 INTERIM REPORT | 1 | HKEx | ||
| 28.08.25 | VENUS MEDTECH-B (02500): ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2025 | - | HKEx | ||
| 18.08.25 | VENUS MEDTECH-B (02500): DATE OF BOARD MEETING | 1 | HKEx | ||
| 05.08.25 | Venus Medtech (Hangzhou) Inc.: Court Sides with Cardiovalve in Edwards patent spat | 241 | PR Newswire | HANGZHOU, China, Aug. 5, 2025 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. ("Venus Medtech", Stock Code: 02500.HK) recently announced a decisive legal victory for its wholly-owned subsidiary... ► Artikel lesen | |
| 22.04.25 | Venus Medtech (Hangzhou) Inc.: Venus Medtech Reports 2024 Annual Results: Profitability Surges with Robust Global Expansion and Innovations | 526 | PR Newswire | HONG KONG, April 22, 2025 /PRNewswire/ -- Venus MedTech (Hangzhou) Inc. (Stock Code: 2500.HK, hereinafter referred to as "Venus Medtech" or the "Company"), a global leader in structural heart... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|
Das Unternehmen VENUS MEDTECH HANGZHOU INC kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VENUS MEDTECH HANGZHOU INC finden Sie auf Wallstreet Online.